Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Slovakia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Slovakia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20091
20102
20111
20122
20132
20141
20161
20171
20181
20191
20221
20233
20241
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated5
Active, not recruiting4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
AstraZeneca4
Eli Lilly and Company4
GlaxoSmithKline4
Pfizer2
Takeda2
Alnylam Pharmaceuticals1
Amgen1
Boehringer Ingelheim1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases27
Atherosclerosis7
Myocardial Infarction7
Stroke7
Diabetes Mellitus, Type 26
Heart Diseases5
Hypertension5
Acute Coronary Syndrome4
Coronary Artery Disease3
Heart Failure3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.